IntegriChain delivers pharma's only comprehensive data, consulting, and business process platform for market access departments. We provide the strategy, data, applications, and business process infrastructure for market access and therapy commercialization for pharmaceutical and life science manufacturers. More than 300 manufacturers rely on our consulting expertise and ICyte Platform to orchestrate their commercial and government payer contracting, patient services, and distribution channels. ICyte is the first and only platform that unites the financial, operational, and commercial data sets required to support therapy access in the era of specialty and precision medicine. With ICyte, pharmaceutical innovators can digitalize their market access operations, freeing up resources to focus on more data-driven decision support.  IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. We are headquartered in Philadelphia, PA, with offices in Ambler, PA; New York, NY Raleigh, NC, and Pune, India.